Central Bank & Trust CO Catalent, Inc. Transaction History

Central Bank & Trust CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 13, 2023	SELL	$31.86 - $67.26 $253,541 - $535,255	-7,958 Reduced 99.75%	20 $0
Q1 2023 Apr 13, 2023	SELL	$45.44 - $74.26 $382,877 - $625,714	-8,426 Reduced 51.37%	7,978 $524,000
Q4 2022 Jan 18, 2023	SELL	$41.39 - $81.0 $41,265 - $80,757	-997 Reduced 5.73%	16,404 $0
Q3 2022 Oct 20, 2022	SELL	$72.36 - $113.1 $886,120 - $1.39 Million	-12,246 Reduced 41.31%	17,401 $1.26 Million
Q2 2022 Jul 22, 2022	SELL	$87.2 - $114.05 $605,168 - $791,507	-6,940 Reduced 18.97%	29,647 $3.18 Million
Q1 2022 Apr 18, 2022	SELL	$94.19 - $124.49 $429,223 - $567,300	-4,557 Reduced 11.08%	36,587 $4.06 Million
Q4 2021 Jan 18, 2022	SELL	$119.57 - $139.07 $478,877 - $556,975	-4,005 Reduced 8.87%	41,144 $5.27 Million
Q3 2021 Oct 19, 2021	BUY	$109.17 - $142.35 $4.93 Million - $6.43 Million	45,149 New	45,149 $6.01 Million

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Central Bank & Trust CO, based on Form 13F filings with the SEC.

Stay updated on Central Bank & Trust CO with notifications on news.